Perimenopause awareness surges in UK as misinformation risks grow

The perimenopause moment: why Britain is talking about it now

Perimenopause has moved from medical textbooks to mainstream conversation in the UK. Celebrities sharing personal experiences, workplace policies adapting to menopausal symptoms, and a surge in online content have made the transitional phase before menopause a cultural talking point. The shift reflects broader societal changes—women in their 40s and 50s now make up nearly a third of the UK workforce, and employers are increasingly pressured to accommodate symptoms that can last for years.

But the visibility comes with complications. According to Dr Paula Briggs, a consultant in sexual and reproductive health, the rapid spread of information has outpaced medical guidance. "We’re seeing women self-diagnosing based on social media posts or celebrity endorsements," she told The Guardian. "Some are even discontinuing treatments because of misinformation about risks that aren’t supported by evidence." The concern isn’t just about individual health choices—it’s about how quickly unvetted advice can shape public understanding of a condition that affects half the population.

The HRT debate: evidence vs. anxiety

Hormone replacement therapy (HRT) sits at the centre of the perimenopause conversation—and the controversy. Once hailed as a solution for symptoms like hot flushes, mood swings, and sleep disruption, HRT has faced fluctuating reputations over the decades. Recent years have seen a resurgence in prescriptions, driven by campaigns like Menopause Mandate and high-profile advocates such as Davina McCall. Yet alongside this revival, misinformation has thrived.

A Guardian investigation found that false claims about HRT’s links to cancer, dementia, and other serious conditions are spreading rapidly online. Some posts suggest natural alternatives are universally safer, despite limited scientific backing. Others exaggerate the benefits of unregulated supplements. Nicola Davis, the paper’s science correspondent, notes that the confusion stems partly from outdated studies. "The data on HRT has evolved, but the public narrative hasn’t kept up," she writes. "Many women are making decisions based on research from the early 2000s, which has since been revised."

The stakes are high. With HRT prescriptions in England rising by 47% since 2021, according to NHS data, the gap between medical consensus and public perception could have real consequences. Some women who might benefit from HRT are avoiding it due to unfounded fears, while others are taking risks with untested treatments.

Beyond biology: the societal ripple effects

The perimenopause conversation is revealing deeper fractures in how the UK handles women’s health. A 2025 report from the Women’s Health Strategy found that 80% of women felt their symptoms were dismissed by healthcare providers, with many waiting years for a diagnosis. The issue intersects with broader debates about workplace equity, NHS funding, and the commercialisation of health advice.

Employers are responding unevenly. While some companies, like Channel 4 and the civil service, have introduced menopause policies, others lag behind. A survey by the Fawcett Society found that only 12% of UK workplaces had formal guidelines for supporting employees through perimenopause or menopause. The lack of standardisation reflects a wider problem: women’s health remains under-researched, underfunded, and often treated as a niche concern rather than a mainstream priority.

The commercial angle adds another layer of complexity. Wellness influencers and supplement brands have capitalised on the perimenopause trend, promoting products with little regulatory oversight. The UK’s Advertising Standards Authority has issued warnings about misleading claims, but enforcement remains patchy. As one NHS GP told NewsMatin, "We’re in a perfect storm—high demand, limited supply of reliable information, and a market eager to fill the gap."

What’s next? The path to clearer information

The perimenopause moment isn’t just a health story—it’s a case study in how medical information spreads in the digital age. The challenge for the UK now is to turn awareness into accuracy. Steps are being taken: the NHS has expanded its menopause resources, and medical schools are updating curricula to include more training on midlife women’s health. But experts argue that systemic change is needed.

Dr Briggs advocates for a public health campaign akin to those for smoking cessation or mental health awareness. "We need clear, consistent messaging that reaches women where they are—whether that’s social media, their GP’s office, or the workplace," she says. Others point to the need for better regulation of health claims online, particularly for supplements and alternative therapies.

For now, the conversation continues to evolve. What’s clear is that perimenopause is no longer a silent transition—it’s a public reckoning. The question is whether the UK can harness the momentum to improve care, or if the noise will drown out the facts.